Payment overview · 2025
General Payments
$29.47
2 reported records · 1 companies
Healthcare provider profile · identity verified
Kimberly Essner, MS-PAC
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant · DEXTER, MO · NPI 1962588210
Verified facts
What the public records show
CMS Open Payments records show Kimberly Essner, MS-PAC received $29.47 in general payments during 2025 across 2 reported records.
Dexcom, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $29.47 | 100.0% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $29.47 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $29.47 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 496 | 94 |
| Amlodipine Besylate | Amlodipine Besylate | 494 | 101 |
| Lisinopril | Lisinopril | 486 | 90 |
| Gabapentin | Gabapentin | 471 | 96 |
| Levothyroxine Sodium | Levothyroxine Sodium | 466 | 80 |
| Meloxicam | Meloxicam | 443 | 84 |
| Omeprazole | Omeprazole | 424 | 72 |
| Metoprolol Succinate | Metoprolol Succinate | 397 | 78 |
| Montelukast Sodium | Montelukast Sodium | 394 | 53 |
| Metformin Hcl | Metformin Hcl | 364 | 61 |
| Furosemide | Furosemide | 360 | 70 |
| Famotidine | Famotidine | 354 | 48 |
| Pantoprazole Sodium | Pantoprazole Sodium | 327 | 58 |
| Hydrochlorothiazide | Hydrochlorothiazide | 316 | 55 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 308 | 57 |
| Mounjaro | Tirzepatide | 257 | 33 |
| Alprazolam | Alprazolam | 239 | 36 |
| Prednisone | Prednisone | 237 | 175 |
| Carvedilol | Carvedilol | 213 | 45 |
| Potassium Chloride | Potassium Chloride | 199 | 33 |
| Tamsulosin Hcl | Tamsulosin Hcl | 198 | 41 |
| Duloxetine Hcl | Duloxetine Hcl | 195 | 27 |
| Tramadol Hcl | Tramadol Hcl | 189 | 30 |
| Ezetimibe | Ezetimibe | 184 | 28 |
| Escitalopram Oxalate | Escitalopram Oxalate | 181 | 37 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 157 | 51 |
| Fluticasone Propionate | Fluticasone Propionate | 156 | 33 |
| Simvastatin | Simvastatin | 153 | 23 |
| Cefdinir | Cefdinir | 152 | 114 |
| Fluoxetine Hcl | Fluoxetine Hcl | 151 | 24 |
| Topiramate | Topiramate | 151 | suppressed |
| Lovastatin | Lovastatin | 148 | 22 |
| Ropinirole Hcl | Ropinirole Hcl | 142 | 21 |
| Alendronate Sodium | Alendronate Sodium | 137 | 24 |
| Celecoxib | Celecoxib | 135 | 29 |
| Pravastatin Sodium | Pravastatin Sodium | 134 | 28 |
| Azithromycin | Azithromycin | 132 | 116 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 131 | 20 |
| Pregabalin | Pregabalin | 130 | 30 |
| Eliquis | Apixaban | 126 | 19 |
| Ondansetron Odt | Ondansetron | 124 | 48 |
| Valsartan | Valsartan | 116 | 24 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 112 | 32 |
| Zolpidem Tartrate | Zolpidem Tartrate | 105 | 17 |
| Losartan Potassium | Losartan Potassium | 104 | 29 |
| Trazodone Hcl | Trazodone Hcl | 102 | 16 |
| Allopurinol | Allopurinol | 99 | 18 |
| Warfarin Sodium | Warfarin Sodium | 99 | suppressed |
| Lorazepam | Lorazepam | 97 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 96 | 26 |
| Sertraline Hcl | Sertraline Hcl | 94 | 16 |
| Paroxetine Hcl | Paroxetine Hcl | 93 | 12 |
| Clopidogrel | Clopidogrel Bisulfate | 90 | 20 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 90 | 19 |
| Linzess | Linaclotide | 88 | suppressed |
| Januvia | Sitagliptin Phosphate | 87 | suppressed |
| Ozempic | Semaglutide | 85 | 14 |
| Metoprolol Tartrate | Metoprolol Tartrate | 83 | 22 |
| Glimepiride | Glimepiride | 80 | 13 |
| Oxybutynin Chloride | Oxybutynin Chloride | 80 | 15 |
| Temazepam | Temazepam | 75 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 73 | 13 |
| Bupropion Xl | Bupropion Hcl | 66 | 16 |
| Xarelto | Rivaroxaban | 66 | 12 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 65 | suppressed |
| Glipizide | Glipizide | 64 | 19 |
| Hydralazine Hcl | Hydralazine Hcl | 62 | 13 |
| Jardiance | Empagliflozin | 60 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 60 | 11 |
| Myrbetriq | Mirabegron | 58 | suppressed |
| Mupirocin | Mupirocin | 56 | 23 |
| Spironolactone | Spironolactone | 56 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 55 | 32 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 55 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 54 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 52 | 17 |
| Benazepril Hcl | Benazepril Hcl | 51 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 51 | suppressed |
| Finasteride | Finasteride | 46 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 45 | 37 |
| Enalapril Maleate | Enalapril Maleate | 45 | suppressed |
| Fluconazole | Fluconazole | 45 | 27 |
| Nystatin | Nystatin | 45 | 22 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 45 | suppressed |
| Baclofen | Baclofen | 43 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 40 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 38 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 38 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 37 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 37 | 13 |
| Cephalexin | Cephalexin | 36 | 28 |
| Diazepam | Diazepam | 36 | suppressed |
| Risperidone | Risperidone | 36 | suppressed |
| Gemfibrozil | Gemfibrozil | 35 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 34 | suppressed |
| Atenolol | Atenolol | 33 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 33 | 20 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 33 | 20 |
| Clonidine Hcl | Clonidine Hcl | 32 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 32 | 13 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 31 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 30 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 28 | 21 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 28 | suppressed |
| Levetiracetam | Levetiracetam | 28 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 28 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 28 | 17 |
| Clindamycin Hcl | Clindamycin Hcl | 27 | 21 |
| Naproxen | Naproxen | 27 | suppressed |
| Rybelsus | Semaglutide | 27 | suppressed |
| Amoxicillin | Amoxicillin | 26 | 23 |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 26 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 26 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 26 | suppressed |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 26 | suppressed |
| Vascepa | Icosapent Ethyl | 26 | suppressed |
| Amantadine | Amantadine Hcl | 24 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 24 | 24 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 24 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 24 | suppressed |
| Nifedipine Er | Nifedipine | 24 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 23 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 23 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 22 | suppressed |
| Levofloxacin | Levofloxacin | 22 | 17 |
| Diclofenac Sodium | Diclofenac Sodium | 21 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 21 | suppressed |
| Lansoprazole | Lansoprazole | 21 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 20 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 20 | suppressed |
| Ibuprofen | Ibuprofen | 20 | suppressed |
| Irbesartan | Irbesartan | 20 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 20 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 19 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 19 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 19 | 13 |
| Amiodarone Hcl | Amiodarone Hcl | 18 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 18 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 18 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 18 | suppressed |
| Synthroid | Levothyroxine Sodium | 18 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Cefprozil | Cefprozil | 17 | 17 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 17 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 17 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 16 | 15 |
| Levemir Flexpen | Insulin Detemir | 16 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 16 | suppressed |
| Primidone | Primidone | 16 | suppressed |
| Procto-Med Hc | Hydrocortisone | 16 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Chlorthalidone | Chlorthalidone | 15 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 15 | suppressed |
| Loperamide | Loperamide Hcl | 15 | 12 |
| Metronidazole | Metronidazole | 15 | suppressed |
| Mirtazapine | Mirtazapine | 15 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 15 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 15 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 14 | suppressed |
| Ketoconazole | Ketoconazole | 14 | suppressed |
| Novolog Flexpen | Insulin Aspart | 14 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 14 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 13 | suppressed |
| Clonazepam | Clonazepam | 13 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 13 | 11 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 12 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 12 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 12 | suppressed |
| Piroxicam | Piroxicam | 12 | suppressed |
| Telmisartan | Telmisartan | 12 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 12 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 12 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 11 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 11 | suppressed |
| Digoxin | Digoxin | 11 | suppressed |
| Techlite Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $29.47 · 2 records | Dexcom, Inc. | Dexcom G6 Transmitter | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error